FEASIBILITY OF THE AUTOMATED COLUMN AGGLUTINATION TECHNIQUE FOR TITRATION OF ANTI-A/B ANTIBODIES IN ABO-INCOMPATIBLE LIVING KIDNEY TRANSPLANTATION

Author:

Matsuura Hideaki1,Sugiura Yukari2,Matsuno Takahiro2,Tomiya Yume3,Shiraki Mari3,Kato Chiaki4,Ishihara Keiko5,Fukami Harue5,Niwa Reiko6,Hayashi Megumi6,Matsushita Tadashi7,Kato Hidefumi6,Watarai Yoshihiko8,Ito Taihei9,Kenmochi Takashi9,Fujii Sumie3,Miura Yasuo10

Affiliation:

1. Department of Cell and Molecular Biology, Fujita Health University, School of Medical Sciences

2. Department of Clinical Laboratory, Fujita Health University Hospital

3. Department of Blood Transfusion, Fujita Health University Hospital

4. Department of Medical Technique, Nagoya University Hospital

5. Department of Clinical Laboratory, Japanese Red Cross Nagoya Daini Hospital

6. Department of Transfusion Medicine, Aichi Medical University Hospital

7. Department of Transfusion Medicine, Nagoya University Hospital

8. Department of Transplant Surgery, Japanese Red Cross Nagoya Daini Hospital

9. Department of Transplantation and Regenerative Medicine, Fujita Health University, School of Medicine

10. Department of Transfusion Medicine and Cell Therapy, Fujita Health University, School of Medicine

Publisher

Japan Society of Transfusion Medicine and Cell Therapy

Subject

Computer Networks and Communications,Hardware and Architecture,Software

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3